NCT03248154

Brief Summary

The objective of the study is to analyze the different implications (such as graft loss and conversion of indeterminate depth burns) of biofilm infections in burn patients. Additionally, it also aims at comparing children's resistance to biofilm infection at wound site than adults'. 300 subjects from 3 different age groups will be enrolled in 3 arms.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 8, 2017

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 14, 2017

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

January 4, 2022

Status Verified

December 1, 2021

Enrollment Period

4.9 years

First QC Date

February 8, 2017

Last Update Submit

December 13, 2021

Conditions

Keywords

BiofilmProcellera

Outcome Measures

Primary Outcomes (1)

  • Detection of biofilm infection in burns

    Tissue biopsies will be tested for presence of bacteria using SEM and culture.

    4 weeks

Secondary Outcomes (2)

  • Assessing graft loss as a result of biofilm infection

    4 weeks post grafting surgery

  • Burn depth measurement

    4 weeks

Other Outcomes (1)

  • Examining children vs adults for biofilm resistance

    2 weeks post grafting surgery

Study Arms (3)

Immunocompetent with 2-14% TBSA

NO INTERVENTION

Immunocompetent with 2-14% TBSA thermal burn subjects. Does biofilm infection result in conversion of partial-thickness burn wounds to full-thickness?

Immunocompromised with >=20% TBSA

EXPERIMENTAL

Immunocompromised patients with large thermal burn \>=20% TBSA. Higher bacterial burden with biofilm infection will result in higher rates of graft loss. Does application of a wireless electroceutical dressing (Procellera) lower biofilm burden compared to burn subjects receiving standard of care therapy?

Device: Procellera

Peripheral blood - all subjects

NO INTERVENTION

All subjects enrolled in arms 1 and 2. Do children have a more robust innate immune response to prevent biofilm infection?

Interventions

burn dressing

Immunocompromised with >=20% TBSA

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Aim 1 and 2:
  • Ages 2 yrs. and older
  • Aim 1:
  • Thermal burns with 2-14% total body surface area (TBSA) injury
  • Patients present within 3 days from the time of thermal burn injury
  • Diagnosed by burn surgeon as having deep partial thickness or indeterminate depth burn (defined as uncertainty between deep second degree or third degree burns)
  • Aim 2:
  • Thermal burns with ≥20% TBSA

You may not qualify if:

  • Aim 1 and 2:
  • Patients with chemical or electrical burns
  • Pregnant women
  • Patient/legal guardian/or next of kin unable to consent
  • Aim 1:
  • Immunosuppressed
  • Taking immune modifying medications
  • Patients requiring \>72 hrs. hospital stay
  • Harmonic Ultrasound \& Doppler Imaging (HUSD) will be used to exclude burn wounds with thrombosed vessels at initial presentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University Hospital East

Columbus, Ohio, 43203, United States

Location

Davis Heart and Lung Research Institute

Columbus, Ohio, 43210, United States

Location

The Ohio State University/Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

Martha Morehouse Medical Plaza 2050 Kenny Road

Columbus, Ohio, 43221, United States

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • Gayle M Gordillo, MD

    Indiana University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 8, 2017

First Posted

August 14, 2017

Study Start

January 1, 2017

Primary Completion

December 1, 2021

Study Completion

December 1, 2022

Last Updated

January 4, 2022

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations